Increased Fecal Bile Acid Excretion in Transgenic Mice With Elevated Expression of Human Phospholipid Transfer Protein
T he level of plasma HDL cholesterol is inversely correlated with the risk of cardiovascular disease. 1 HDL can remove cholesterol from the arterial wall and subsequently transport the lipid to the liver, [2] [3] [4] where it can be converted into bile acids or secreted directly into the bile. This process is called reverse cholesterol transport. The conversion of cholesterol into bile acids and their subsequent fecal excretion is quantitatively the most important way for elimination of cholesterol from the body and the final step in reverse cholesterol transport. 5 There are 2 major pathways involved in bile acid synthesis. The classical or neutral route in bile acid biosynthesis is initiated by 7␣-hydroxylation of cholesterol catalyzed by the major rate-limiting enzyme cholesterol 7␣-hydroxylase, which is located in the smooth endoplasmic reticulum. 6, 7 An alternative pathway in bile acid synthesis is the so-called acidic pathway initiated by the conversion of cholesterol by the enzyme sterol 27-hydroxylase, which is located in the inner mitochondrial membrane. 6 -8 The rate of bile acid synthesis is under control of different molecular mechanisms in which nuclear receptors are involved. In most species, the liver X-receptor ␣ (LXR␣) is involved in the feedforward regulation of cholesterol 7␣-hydroxylase by cholesterol, whereas the feedback regulation by bile acids is mediated via the farnesoid X-receptor (FXR). 9 Phospholipid transfer protein (PLTP) plays a critical role in HDL metabolism. PLTP facilitates the transfer of phospholipids between lipoproteins and modulates HDL size and composition. 10, 11 Recent studies suggest that PLTP can have a potentially antiatherogenic role via its effect on HDL. It was shown that transgenic mice overexpressing human PLTP have an increased generation of pre-␤-HDL, which is a very efficient acceptor of cholesterol from peripheral tissues. 12 On the other hand, plasma levels of total HDL were decreased by an accelerated catabolism of HDL particles. 13, 14 Recently, an unexpected cellular role of PLTP was found in PLTP knockout mice, in which it was demonstrated that PLTP can regulate the secretion of apolipoprotein-B-containing lipoproteins. 15 PLTP deficiency not only resulted in a reduced production and plasma levels of apolipoprotein-B-containing lipoproteins but also in increased antioxidant potential 16 and in markedly decreased atherosclerosis. 15 Therefore, increased PLTP expression seems to have various effects on lipoprotein metabolism.
In the present study, we investigated the metabolic fate of HDL cholesterol in transgenic mice overexpressing human PLTP by studying the way it is handled by the liver. Our data demonstrate that elevation of PLTP activity results in a rapid disposal of cholesterol from the body via increased bile acid excretion, suggesting an enhanced HDL-mediated reverse cholesterol transport.
Methods Animals
HuPLTP-overexpressing mice on a C57Bl/6 background (line A2) and wild-type C57Bl/6 as controls were used. 17, 18 The experiments were performed with adult male mice, which were maintained on 12-hour dark and 12-hour light cycles and allowed free access to chow and water. Body weight of the mice and the consumption of diet and water were recorded weekly and did not differ during the whole experimental period. Liver mass of the PLTP overexpressing mice was the same as of the wild-type mice. Institutional guidelines for animal care were observed in all experiments.
Assay of Plasma PLTP Activities
Plasma PLTP activity was measured using a liposome vesicles-HDL system, as described. 12 In short, plasma samples were incubated with [
3 H]phosphatidyl-choline-labeled liposomes and an excess of pooled normal HDL for 45 minutes at 37°C, followed by precipitation of the liposomes with a mixture of NaCl, MgCl 2 , and heparin (final concentrations, 230 mmol/L, 92 mmol/L, and 200 U/mL, respectively). After centrifugation, the radioactivity transferred to HDL was counted in the supernatant. Plasma was diluted 50-fold (wild-type mice) or 500-fold (transgenic mice) before assay, and the measured PLTP activities were linearly correlated with the amount of diluted plasma (12.5 to 25 L) used in the incubations. All assays were performed in duplicate, using the same batch of substrates. 
Measurement of Serum Lipids and Lipoproteins

Determination of Lipoprotein Lipase and Hepatic Lipase Activity
Postheparin plasma from fasted mice (4 hours) was collected from the retro-orbital plexus 20 minutes after injection of heparin (1.0 U/g body weight). The assay of postheparin plasma-lipolytic activity was performed in the presence or absence of 1 mol/L NaCl to estimate both the lipoprotein lipase (LPL) and hepatic lipase (HL) activity. LPL activity was calculated as the portion of total lipase activity inhibited by 1 mol/L NaCL. 19 Enzyme Activities and mRNA Levels of Cholesterol 7␣-Hydroxylase, Sterol 27-Hydroxylase, and HMG-CoA-Reductase and
Measurement of Liver Lipids
Enzymatic activities of cholesterol 7␣-hydroxylase and sterol 27-hydroxylase in mouse liver microsomes and mitochondria, respectively, were determined as described previously, 20 measuring the mass conversion of cholesterol into 7␣-and 27-hydroxycholesterol. HMG-CoA-reductase activity in freshly isolated liver microsomes 21 and liver lipids 20, 22 after lipid extraction 23 were measured as described. Isolation of total RNA and subsequent electrophoresis, Northern blotting, probes, and hybridization techniques were performed as described previously. 20, 24, 25 The GAPDH mRNA or 18S rRNA was used as an internal standard to correct for differences in the amount of total RNA applied onto the gel. mRNA levels were quantitated as described previously. 20 
Determination of Concentration and Composition of Bile Acids and Neutral Sterols in Feces
Fecal production during a 3-day period was separated from the wood shavings. Fecal samples were lyophilized and weighed. For extraction of bile acids, an aliquot of dried feces (5 mg) was incubated in 1 mL alkaline methanol (methanol: 1 mol/L NaOH 3:1 [vol/vol]) for 2 hours at 80°C in screw-capped tubes using nor-hyodeoxycholate as an internal standard. Then 9 mL of distilled water was added, and the tubes were mixed and centrifuged. The supernatant was subsequently applied to a prepared Sep-Pak C18 solid-phase extraction cartridge. 26 After a clean up by wash procedures, bile acids were eluted with 75% methanol. The solvent was evaporated to dryness, and the bile acids were derivatized by incubation with 50 L trifluoroacetic anhydride and 30 L 1,1,1,3,3,3-hexafluoro-2-propanol for 1 hour at 60°C. The bile acid derivatives were separated on a 25 mϫ0.25 mm capillary GC column (CP Sil 5B, Chrompack International) in a 3800 GC gas chromatograph (Varian) equipped with a flame ionization detector. The injector and the flame ionization detector were kept at 300°C. The column temperature was programmed from 230 to 280°C. Bile acid derivatives were introduced by split injection (split ratio, 20:1). Quantitation was based on the area ratio of the individual bile acid to the internal standard.
To extract neutral sterols from feces, dried feces (10 mg) were treated with 1 mL alkaline methanol as described for bile acid measurement using 5␣-cholestane as internal standard. After treatment, the tubes were cooled to room temperature and the neutral sterols were extracted 3 times with 3 mL petroleum ether. The combined petroleum ether layers were evaporated to dryness, and the neutral sterols were silylated by DMF-Silprep (Alltech). Analysis of the sterol derivatives was performed by GC, applying the same column as for the bile acids. Quantitation was based on the area ratio of the individual neutral sterol to the internal standard 5␣-cholestane.
Determination of Biliary Lipid Secretion
Separate groups of animals were used for these experiments. The common bile duct of anesthetized wild-type and HuPLTPoverexpressing mice was ligated, and the gallbladder was cannulated. Bile was collected in 15-minute intervals for 105 minutes. Cholesterol and phospholipid in bile were determined after lipid extraction, 23 as described previously. 22 Total bile acid in bile was determined using a commercial kit from Nycomed. The biliary bile acid composition was determined by gas liquid chromatography. 20 The bile acid pool size was determined from the area under the curve during the first 90 minutes of bile collection.
Statistics
Data were analyzed statistically using the nonparametric MannWhitney test with the level of significance selected to be PϽ0.05.
Values are expressed as meanϮSD
Results
Effect of HuPLTP Overexpression on Plasma and Hepatic Lipid Levels
PLTP activity was measured in plasma samples of HuPLTPoverexpressing and wild-type mice. In the PLTPoverexpressing mice, the PLTP activity was 15-fold higher compared with wild-type mice ( Table 1) . The increase in PLTP activity resulted in dramatically reduced total plasma cholesterol levels (Ϫ92%), mainly in the HDL fraction ( Figure 1 ). The amounts of phospholipids and triglycerides in plasma were also decreased ( To investigate changes in hepatic lipid content, we measured free cholesterol, cholesteryl esters, triglycerides, and phospholipids in the livers of wild-type and HuPLTPoverexpressing mice (Table 2 ). Whereas free cholesterol levels were not changed, cholesteryl ester content in the overexpressing mice was 1.8-fold higher compared with the wild-type mice. The hepatic triglyceride content in the PLTP-overexpressing mice did not change significantly (Table 2), whereas phospholipids decreased significantly (Ϫ22%).
Bile Analyses
To investigate the metabolic fate of hepatic cholesterol, we measured bile flow and biliary output of cholesterol and bile acids in wild-type and HuPLTP-overexpressing mice. As shown in Table 3 , bile flow is significantly higher in the HuPLTP-overexpressing mice. In addition, bile acid and cholesterol output were both significantly enhanced (2.0-and 2.5-fold, respectively) in the HuPLTP-overexpressing mice. The bile acids present in the bile were predominantly cholate (52%) and muricholate (␣, ␤, ) (41%) and did not differ between the groups. In addition to a higher bile acid output, the bile acid pool size, as determined from the washout curves, was 2.4-fold larger in the HuPLTP transgenic mice compared with the wild-type mice (100Ϯ40% versus 237Ϯ53%; PϽ0.05). Next to this, phospholipid output was also 1.7-fold higher in HuPLTP transgenic mice compared with the wild-type mice. Because excretion of all biliary lipids was elevated, the changes in biliary lipid output did not have an effect on the lithogenicity index of the bile (1.19Ϯ0.44 versus 1.41Ϯ0.18; nϭ6).
Fecal Cholesterol and Bile Acids, Hepatic Enzyme Activities, and mRNA Levels
To investigate whether the increased biliary bile acid and cholesterol excretion resulted in an enhanced fecal sterol output, we determined the bile acid and neutral sterol content in the feces of wild-type and HuPLTP-overexpressing mice. As shown in Figure 2 , fecal neutral sterol excretion did not change, whereas fecal bile acid excretion was significantly increased (1.4-fold), which reflects an increased bile acid synthesis. The fecal bile acid composition was not different in the HuPLTP-overexpressing mice compared with the wildtype mice. The bile acids present in the feces were predominantly deoxycholate (40%), muricholate (␣, ␤, ) (39%), and cholate (10%), with minor amounts of lithocholate, chenodeoxycholate, hyodeoxycholate, and ursodeoxycholate.
The increase in bile acid synthesis did not result from an induction in the expression of cholesterol 7␣-hydroxylase or sterol 27-hydroxylase, because we could not detect any significant changes in the enzyme activity and mRNA levels of these bile acid synthetic enzymes (Table 4) .
We additionally examined whether the increased expression of PLTP and the subsequently enhanced hepatic cholesteryl ester content and bile acid synthesis resulted in a change in cholesterol synthesis. HMG-CoA reductase activity measured in liver microsomes was significantly lower (Ϫ32%) in the PLTP-overexpressing mice compared with the wild-type mice (Table 4) .
Discussion
In this study, we showed that hepatic overexpression of human PLTP in mice results in enhanced bile acid synthesis and increased fecal bile acid excretion.
Overexpression of human PLTP in mice either by a transgene or via adenoviral-mediated gene transfer leads to a decrease in plasma HDL concentration. [12] [13] [14] The decrease in plasma HDL levels is caused by an accelerated clearance of HDL cholesteryl esters by the liver 13 and leads to elevated levels of cholesteryl esters in the liver of PLTP transgenic mice, as shown in the present study. The metabolic fate of this enlarged amount of hepatic cholesteryl esters is unknown and subject of the present study. The elevated level of cholesteryl esters in the liver resulted in an expected downregulation of the hepatic cholesterol synthesis, as reflected by a reduction in HMG-CoA-reductase activity. This can also contribute to the decrease in plasma cholesterol levels found in the PLTP transgenic mice. It is well-known that elevated levels of hepatic cholesterol can induce the expression of cholesterol 7␣-hydroxylase in different animal models via LXR␣-mediated gene transcription. 9 However, the relatively modest increase in hepatic cholesteryl ester in the PLTP transgenic mice did not result in enhanced enzyme activities nor in elevated mRNA levels of cholesterol 7␣-hydroxylase and sterol 27-hydroxylase. Possibly, the amount of regulatory cholesterol metabolites (oxysterols) remains too low to induce cholesterol 7␣-hydroxylase expression. It should be noted that although there was an increase in hepatic cholesterol levels, the absolute cholesterol content is still low compared with cholesterol-fed mice or rats. 20, 27 In the latter experiments, hepatic cholesteryl ester levels were 8-to 13-fold increased, compared with an approximately 2-fold increase in the PLTP transgenic mice, resulting in a 2-to 3-fold increase of cholesterol 7␣-hydroxylase expression. Moreover, the enlarged bile acid pool, as found in the PLTP-overexpressing mice, may also suppress the expression of the gene via the nuclear bile acid receptor FXR and SHP. This would result in a balance between LXR␣-and FXR/SHP-mediated gene transcription, resulting in the absence of an effect on expression of the bile acid synthetic enzymes. Nevertheless, we found a higher production of bile acids, as demonstrated by an enhanced fecal output. We conclude, therefore, that the bile acid synthesis is elevated as a result of an increased flux of cholesterol through the bile acid synthetic pathway without upregulation of cholesterol 7␣-hydroxylase or sterol 27-hydroxylase.
Next to an increased biliary bile acid excretion, both the biliary phospholipid and cholesterol output were also higher in the transgenic mice compared with the wild-type mice.
This increase in biliary secretion of bile acids and cholesterol could be attributable to an increased expression of the transporter genes BSEP, ABCG5, and ABCG8, which have been shown to be upregulated by FXR and LXR␣ as a consequence of a higher pool of bile acids and oxysterols in the transgenic mice. 28, 29 Consequently, the elevated biliary cholesterol output did not result in an increased lithogenicity index, which is an important indicator of bile stone formation. 30 Elevation of removal of HDL particles as part of HDL-mediated cholesterol transport induced by upregulation of PLTP activity is therefore an elegant way to properly remove cholesterol from the body, ie, in the form of bile acids.
In the present study, only transgenic mice with relatively high expression of PLTP were studied. However, in a series of transgenic mice with increasing PLTP expression, a PLTP dose-dependent relation was found with both plasma HDL levels and atherosclerosis susceptibility, 18 suggesting that at least these phenotypic effects are not restricted to A2 line. In PLTP mice with 4.5-fold elevated PLTP activity (lines P4 and A3), we also found an increased elevated fecal bile acid output (1.2-fold). Putting all of the data together from mice from the 4 PLTP transgenic lines published before, a statistically significant positive correlation (R 2 ϭ0.42; PϽ0.0005) was observed between PLTP expression and fecal bile acid output (results not shown), indicating that the effects described in this study are not restricted to the line of transgenic mice used.
In contrast to the PLTP-overexpressing mice, other mouse models in which the HDL-mediated uptake of cholesterol by Bile was collected for 15 minutes after creation of a gall bladder fistula in wild-type and HuPLTP overexpressing mice. Bile flow was determined gravimetrically. Output rates of bile acids, cholesterol, and phospholipids were calculated by multiplying bile flow and concentration.
A significant difference is indicated by an asterisk (*PϽ0.05). In liver homogenates of wild-type and HuPLTP overexpressing mice fed a chow diet free cholesterol (FC), cholesteryl esters (CE), triglycerides (TG) and phospholipids (PL) were determined after lipid extraction (see Methods).
A significant difference is indicated by an asterisk (*PϽ0.05).
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the liver was stimulated did not show changes in bile acid synthesis. For example, hepatic overexpression of the HDLreceptor SR-BI in mice resulted in an increased biliary cholesterol excretion but not in an elevated bile acid output. 31, 32 Similarly, adenovirus-mediated gene transfer of the recently identified cholesterol and phospholipid transporter ABCG1 led to an increased reverse cholesterol transport and subsequently to an enhanced biliary cholesterol secretion without affecting biliary bile acid secretion. 33 A drawback of an increase in biliary cholesterol without a simultaneous elevation of biliary bile acid excretion is the negative effect on cholesterol gallstone formation and the adverse changes in lipoprotein metabolism, because biliary cholesterol can be taken up again in the intestine. In contrast, when cholesterol is converted into bile acids, there will be a proportionally increased fecal excretion of bile acids, resulting in the net loss of cholesterol from the body. The observed increase in biliary lipid secretion resulted in an enhanced fecal bile acid excretion. However, we did not find a change in the amount of fecal neutral sterols. Because bile acids play an important role in the solubilization of cholesterol, the elevated amount of bile acids in the intestine may consequently increase cholesterol absorption, resulting in unchanged fecal neutral sterol secretion.
Recently it was found that PLTP deficiency in mice results in reduced production and levels of apolipoprotein B-containing lipoproteins and markedly decreased atherosclerosis, 15 indicating that, next to an effect in plasma, PLTP can exert an effect at the cellular level. We recently found a modest increase (Ͻ1.5-fold) of VLDL secretion in PLTPoverexpressing mice. 18, 34 In the present study, however, we found strongly decreased levels of plasma triglycerides in the PLTP-overexpressing mice. This is in agreement with studies in which adenovirus-mediated overexpression of PLTP was studied. 13, 14 Thus, high levels of PLTP activity seem to result in a decrease in plasma triglycerides. In addition, the HuPLTP-overexpressing mice have reduced LPL and HL activity and show no difference in ketone bodies, which are a marker of hepatic ␤-oxidation. These results suggest that elevated PLTP expression causes remodeling of lipoproteins and results in whole particle uptake of triglycerides-rich lipoproteins as well as enlarged HDL particles. 13, 14 Whether increases in expression of PLTP in humans also will lead to an increased removal of cholesterol from the body is not known. Recently, Eriksson et al 35 showed that HDL elevation by infusion of recombinant proapolipoprotein A-I in humans and subsequent enhancement of reverse cholesterol transport resulted in an increased fecal steroid excretion, indicating that modulating HDL metabolism in humans may be a useful way to remove cholesterol, ie, in the form of bile acids and cholesterol.
We recently found that elevated plasma PLTP activity results in increased susceptibility of diet-induced atherosclerosis in heterozygous LDL-receptor knockout mice, probably caused by a decrease in plasma HDL. 18 However, PLTP also has antiatherogenic properties, as revealed by increased fecal bile acid secretion described in the present study. In addition, we previously reported that elevated PLTP leads to an increase in the formation of pre-␤-HDL, which is a very efficient receptor of cellular cholesterol. 12 Thus, PLTP seems to have atherogenic and antiatherogenic properties. Although the atherogenic potential apparently dominates in heterozygous LDL-receptor knockout mice fed a high-fat, high-cholesterol diet, this is not necessarily true for other animal models of atherosclerosis or humans. Additional studies are needed to unravel the exact mechanism by which elevated PLTP activity affects the development of atherosclerosis.
The high level of PLTP expression used in the present study resulted in higher plasma PLTP activity than that observed in men. However, atherosclerosis in humans is a lengthy process in which a more modest elevation of PLTP activity could have significant long-term effects. Recent studies indicate that LXR activation leads to increased expression of PLTP. 36 However, PLTP activity was only measured by Cao et al, 36 who found a modest increase at very high doses of the LXR agonist T090131. 37, 38 In addition, treatment with LXR agonist affects the expression of several genes involved in lipid metabolism and may result in a large increase in liver triglycerides. 38 Some of the reported effects on HDL metabolism also occur in PLTP-deficient mice, indicating that they are not dependent on PLTP activity. 36 Thus, treatment with LXR agonists will have other effects in addition to an increase of PLTP activity. Future studies will have to establish whether modulation of PLTP activity is feasible to achieve enhanced bile acid excretion in humans. Enzyme activities and mRNA levels were measured in wild-type and HuPLTP overexpressing mice fed a chow diet.
A significant difference is indicated by an asterisk (*PϽ0.0001).
